铜诱导神经元节约,铁素1-独立的星细胞毒性通过氧化应激介导的氧化应激
Jenna R Gale1, Karen Hartnett-Scott1, Madeline M Ross1
1Department of Neurobiology and Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Journal of neurochemistry
|September 13, 2023
概括
铜elaclomol (CuES) 对星体细胞有毒,但对神经元无毒,这表明在质细胞中存在独特的铜毒性机制. 抗氧化剂和金属氨酸可以防止CuES诱导的细胞死亡,突出显示了质瘤的潜在治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 毒理学 毒理学 毒理学
背景情况:
- 铜对细胞功能至关重要,但在失调时是有毒的.
- 铜埃莱斯克洛莫尔 (CuES) 正在研究用于质瘤治疗.
- 了解CuES对神经元和星球细胞的影响至关重要.
研究的目的:
- 研究CuES在神经元和星球细胞上的差异性毒性.
- 阐明质细胞中CuES诱导的细胞死亡背后的机制.
- 探索潜在的防护策略,防止CuES的毒性.
主要方法:
- 在实验室中,主要神经元和天体细胞暴露于CuES.
- 评估细胞活力和细胞死亡途径.
- 对氧化应激标志物和脂质过氧化物的分析.
- 对抗氧化剂和金属氨酸的保护作用的评估.
主要成果:
- 天体细胞对CuES毒性的敏感性很高,而神经元则具有耐药性.
- 由CuES诱导的天体细胞死亡是由氧化应激介导的,由脂质过氧化证明.
- 抑制cuproptosis途径没有影响CuES的毒性.
- 抗氧化剂治疗和金属氨酸诱导保护了天体细胞免受CuES的毒性.
结论:
- CuES具有独特的质细胞选择性毒性特征,与其他金属毒素形成鲜明对比.
- 氧化应激是CuES诱导的质毒性的关键媒介.
- 金属氨酸可能会导致神经元对CuES的耐药性.
- 这些发现提供了关于CuES神经毒性和质瘤潜在治疗干预措施的见解.
相关概念视频
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


